The anti-AD effect of BBR relies on the amelioration of ER stress, which can inhibit the overactivation of GSK3β to prevent the hyperphosphorylation of tau, as well as inhibit eIF2α activation to reduce BACE1 expression (Figure 8). This evidence concerns the gene EIF2A and Alzheimer disease.